Access to this symposium requires KEY ZONE access (paid
registration) to HDCN. For information about subscribing to HDCN,
please go to this link.
|
The High Risk Transplant Patient |
|
|
|
wma |
mp3 |
Kiberd B. |
The Elderly with Cardiovascular Disease |
|
|
|
|
Discussion |
|
|
|
Wali R. |
Heart Failure and Renal Transplantation |
|
|
|
|
Discussion |
|
|
|
Adey D. |
The Patient with High Risk of Recurrence |
|
|
|
|
Discussion |
|
|
|
Chapman J. |
The Patient with Malignancy |
|
|
|
|
Discussion |
|
|
|
Chandraker A. |
The Sensitized Patient |
|
|
|
|
Discussion |
|
|
|
The Pathway to Approval of Novel Agents for Renal Diseases |
|
|
|
wma |
mp3 |
Greene T. |
Outcome Measures in Renal Disease: How Good Are Surrogates? |
|
|
|
Throckmorton D. |
FDA Perspective on Approval of Novel Agents for Renal Disease |
|
|
|
Lewis E. |
Lessons Learned from Pivotal Trials of New Drugs for Renal Disease |
|
|
|
|
Discussion |
|
|
|
Visit us next week for new topics !
|
 |
Audio
tapes from this Symposia can be purchased from:
|
|